Raleigh, NC – According to filings with the U.S. Securities and Exchange Commission, Contego Medical is raising $17,500,050.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Ravish Sachar played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Contego Medical

Contego Medical, Inc. is a medical device company dedicated to the development of novel embolic protection devices for cardiovascular and peripheral vascular procedures. The companys integrated embolic protection (IEP) platform, which combines embolic protection and treatment into one device, is designed to simplify catheter-based procedures and improve patient outcomes. Contego Medicals portfolio is transforming cardiovascular and endovascular interventions by making existing procedures safer without increasing complexity or compromising performance. The Company has two devices with CE mark designation: The Paladin Carotid Post-Dilation Balloon, the first and only angioplasty balloon with IEP Technology aimed at reducing stroke risk and The Vanguard IEP Peripheral Angioplasty System with Integrated Embolic Protection. Additional devices are in development and under clinical investigation to address unmet needs in embolic protection in multiple vascular beds.

To learn more about Contego Medical, visit http://contegomedical.com/

Contact:
Ravish Sachar, Chief Executive Officer
919-459-7250
rsachar@contegomedical.com
https://www.linkedin.com/in/ravish-sachar-md-facc-40017a6/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved